AI Generated Image
Blood test detects 90% of aggressive prostate cancer cases compared to standard screenings
Fox News • • health
Key Points:
- A new blood test called Stockholm3 has shown greater accuracy in detecting aggressive prostate cancer compared to the traditional PSA test, identifying 90% of aggressive cases versus 74% by PSA in a study of over 12,000 men.
- The Stockholm3 test missed significantly fewer serious cancer cases while maintaining a similar rate of false positives as PSA, potentially allowing for earlier detection without increasing unnecessary follow-ups.
- Researchers suggest that Stockholm3 could improve prostate cancer screening by reducing invasive procedures like MRIs and biopsies and enabling treatment while the disease is still curable.
- Despite promising results, Stockholm3 is currently investigational and not available in the U.S.; the manufacturer plans to seek FDA approval and conduct further studies including U.S. data.
- Early detection of aggressive prostate cancer is crucial, as the five-year survival rate is nearly 100% when the disease is confined to the prostate, highlighting the importance of improved screening methods.
